Literature DB >> 10796892

Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels.

F Calabrese1, P Pontisso, E Pettenazzo, L Benvegnù, A Vario, L Chemello, A Alberti, M Valente.   

Abstract

In hepatitis C virus (HCV) infection, mechanisms responsible for liver cell damage are still poorly understood and both necrosis and apoptosis may be operative. By using terminal deoxynucleotydil transferase-mediated d-UTP-biotin nick-end labeling (TUNEL) we have evaluated and quantified apoptosis in liver biopsy specimens from 61 patients with chronic hepatitis C. All patients had detectable apoptotic cells in the liver. Presence of increased apoptotic activity was confirmed in selected cases by electron microscopy and by DNA gel electrophoresis. The amount of liver cell apoptosis expressed as apoptotic index, ranged between 0.01% to 0.54% and showed a positive correlation with histological activity grading (P <.0005) and with the amount of infiltrating CD8-positive cells (P =. 01). Apoptosis did not correlate with transaminase levels or with HCV load and genotype. These results support the concept that immune-mediated apoptosis may play a role in the pathogenesis of chronic hepatitis C and indicate that this type of reaction may occur in the absence of significant alanine transaminase (ALT) elevation, thus explaining the lack of correlation between biochemical activity and liver histological damage.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10796892     DOI: 10.1053/he.2000.7123

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  36 in total

1.  Comparison of ischemic preconditioning and intermittent and continuous inflow occlusion in the murine liver.

Authors:  Hannes A Rüdiger; Koo J Kang; David Sindram; Hans M Riehle; Pierre A Clavien
Journal:  Ann Surg       Date:  2002-03       Impact factor: 12.969

2.  Expression of bcl-2 protein in chronic hepatitis C: effect of interferon alpha 2b with ribavirin therapy.

Authors:  Panasiuk Anatol; Prokopowicz Danuta; Dzieciol Janusz; Panasiuk Bozena
Journal:  World J Gastroenterol       Date:  2005-05-21       Impact factor: 5.742

Review 3.  Apoptosis in animal models of virus-induced disease.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

Review 4.  Hepatitis C virus infection and apoptosis.

Authors:  Richard Fischer; Thomas Baumert; Hubert-E Blum
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

Review 5.  Caspase inhibitors for the treatment of hepatitis C.

Authors:  Howard C Masuoka; Maria Eugenia Guicciardi; Gregory J Gores
Journal:  Clin Liver Dis       Date:  2009-08       Impact factor: 6.126

6.  Hepatitis C virus infection induces apoptosis through a Bax-triggered, mitochondrion-mediated, caspase 3-dependent pathway.

Authors:  Lin Deng; Tetsuya Adachi; Kikumi Kitayama; Yasuaki Bungyoku; Sohei Kitazawa; Satoshi Ishido; Ikuo Shoji; Hak Hotta
Journal:  J Virol       Date:  2008-09-03       Impact factor: 5.103

7.  Expression of hepatitis C virus envelope protein 2 induces apoptosis in cultured mammalian cells.

Authors:  Li-Xin Zhu; Jing Liu; You-Hua Xie; Yu-Ying Kong; Ye Ye; Chun-Lin Wang; Guang-Di Li; Yuan Wang
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

8.  Cre-estrogen receptor-mediated hepatitis C virus structural protein expression in mice.

Authors:  Batbayar Tumurbaatar; Yixiao Sun; Tehsheng Chan; Jiaren Sun
Journal:  J Virol Methods       Date:  2007-07-12       Impact factor: 2.014

9.  Hepatitis C virus core protein leads to immune suppression and liver damage in a transgenic murine model.

Authors:  Carolina Soguero; Myungsoo Joo; Kimberly A Chianese-Bullock; Duong Tony Nguyen; Kenneth Tung; Young S Hahn
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 10.  Chronic hepatitis C virus infection: Serum biomarkers in predicting liver damage.

Authors:  Pamela Valva; Daniela A Ríos; Elena De Matteo; Maria V Preciado
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.